Growth Factors vs. Peptides vs. Exosomes: What's Actually In Your Serum
If you've spent any time in the skin longevity aisle lately, you've seen these three words everywhere: growth factors, peptides, exosomes. They get used almost interchangeably in marketing copy, which is a problem, because they are not the same thing, they don't do the same job, and a serum built around only one of them is telling you an incomplete story about what it can do.
Here's what each one actually is, what it actually does, and why the distinction matters if you're trying to buy skincare based on substance rather than buzzwords.
Growth Factors: The Signal
Growth factors are proteins your skin already produces naturally when it's healing or renewing itself. Think of them as the messengers: they bind to receptors on skin cells and tell those cells what to do next, whether that's producing more collagen, migrating to repair a wound, or dividing to replace older cells.
The catch is that natural growth factor production slows down with age. Fewer signals reach fewer receptors, and the skin's own repair and renewal cycle loses momentum. Topical growth factors are, in effect, a way of restoring some of that signaling capacity from the outside.
What they're good at: initiating cellular activity. What they can't do alone: sustain that activity or rebuild the structural matrix underneath it.
Peptides: The Instruction Set
Peptides are short chains of amino acids, essentially fragments of proteins, that act as more specific instructions to skin cells. Different peptide sequences trigger different responses: some signal collagen production, some help calm inflammatory pathways, some support the skin barrier directly.
Where growth factors are broad signals, peptides tend to be narrower and more targeted. That specificity is useful, but it also means a single peptide is solving a single problem. A serum built on one peptide is optimized for one mechanism, not the full picture of what aging skin needs.
What they're good at: precision, targeting specific pathways. What they can't do alone: replace the broader signaling that growth factors provide, or supply the raw material transfer that exosomes handle.
Exosomes: The Delivery System
Exosomes are the newest of the three to reach mainstream skincare, and they're also the most misunderstood. Exosomes are tiny extracellular vesicles, essentially cellular shipping containers, that cells use to communicate with each other by transferring proteins, growth factors, and genetic material like RNA between cells.
In skincare, exosomes function less like a single active ingredient and more like a delivery infrastructure. Rather than depositing one type of molecule, they carry a complex cargo of regenerative signals directly to the cells that need them. Where exosomes come from matters. Fibroblast-derived exosomes carry a cargo focused on collagen and structural repair. Exosomes derived from other sources, such as umbilical cord or bone marrow tissue, carry different cargos with different regenerative signals. A formula built on a single exosome source only delivers one type of message. A formula that draws from multiple sources delivers a broader regenerative signal.
What they're good at: comprehensive intercellular communication and delivery of multiple regenerative signals at once. What they can't do alone: they still work best alongside the signaling proteins and targeted peptides that prime the skin to receive them.
Why the Combination Is the Point
None of these three ingredient categories replaces the other two. Growth factors initiate. Peptides direct. Exosomes deliver a broader regenerative cargo. A formula that leans on only one of them is, by definition, addressing only one part of the skin's regenerative process.
This is the thinking behind BioBlend Technology™, INVO's proprietary ingredient platform: it combines growth factors, peptides, and exosomes, drawing on multiple exosome sources, including fibroblast, umbilical cord, and bone marrow derived exosomes, to create a more complete regenerative signal rather than relying on any single mechanism.
That multi-source approach has been independently characterized by third-party labs, including Clarkson University, RayBiotech Life, System Biosciences, UCLA, and Bio Discovery Labs. It's worth being precise about what that means: these evaluations characterize the composition and biological activity of the formula. They are not clinical efficacy trials, and we don't present them as such. If you want to see how INVO documents this distinction, the full breakdown lives on our science page.
The Takeaway
The next time you see "growth factors," "peptides," or "exosomes" on a label, the useful question isn't which one sounds most advanced. It's whether the formula is using them together, in a way that reflects how skin actually regenerates, or leaning on one mechanism and calling it complete.
What's the difference between growth factors and peptides in skincare?
Growth factors are proteins that signal skin cells to begin repair and renewal processes. Peptides are shorter amino acid chains that target more specific pathways, like collagen production or barrier support. Growth factors initiate broad activity; peptides direct narrower, specific responses.
Are exosomes better than peptides for skin?
They're not competing technologies, they serve different roles. Peptides deliver targeted instructions. Exosomes deliver a broader cargo of regenerative signals, including proteins and growth factors, directly between cells. Formulas that combine both address more of the regenerative process than either alone.
Do all exosomes in skincare come from the same source?
No. Exosome source affects what regenerative cargo they carry. Fibroblast-derived exosomes focus on structural and collagen-related signals; exosomes from other sources, like umbilical cord or bone marrow tissue, carry different signal profiles. Formulas using a single source deliver a narrower signal than formulas drawing from multiple sources.
